Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 1294 entries
View as:

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Phase: N/A Priority: Normal
NCT ID: NCT05579249 Org: User:
Start: 01/19/23 End: 11/27/24 Due: 11/27/25

Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

Phase: N/A Priority: Normal
NCT ID: NCT06283641 Org: User:
Start: 04/08/24 End: 01/13/25 Due: 01/13/26

A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

Phase: N/A Priority: Normal
NCT ID: NCT02696148 Org: User:
Start: 03/14/16 End: 04/13/17 Due: 04/13/18

Safety and Efficacy of Long-term Somatropin Treatment in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01543880 Org: User:
Start: 07/31/03 End: 06/30/14 Due: 06/30/15

Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756

Phase: N/A Priority: Normal
NCT ID: NCT01278160 Org: User:
Start: 01/31/11 End: 09/30/11 Due: 09/30/12

Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01272193 Org: User:
Start: 01/31/11 End: 09/30/11 Due: 09/30/12

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)

Phase: N/A Priority: Normal
NCT ID: NCT04261933 Org: User:
Start: 02/13/20 End: 05/25/21 Due: 05/25/22

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06717698 Org: User:
Start: 12/02/24 End: 09/29/26 Due: 09/29/27

Comparison of Three Liraglutide Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01514487 Org: User:
Start: 01/13/05 End: 03/30/05 Due: 03/30/06

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT06323174 Org: User:
Start: 03/19/24 End: 12/26/25 Due: 12/26/26

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06542874 Org: User:
Start: 08/07/24 End: 10/24/25 Due: 10/24/26

Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01563471 Org: User:
Start: 10/31/01 End: 07/31/02 Due: 07/31/03

Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT05016882 Org: User:
Start: 08/31/21 End: 03/14/25 Due: 03/14/26

A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

Phase: N/A Priority: Normal
NCT ID: NCT07004322 Org: User:
Start: 05/26/25 End: 04/07/26 Due: 04/07/27

A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03674866 Org: User:
Start: 10/29/18 End: 04/26/19 Due: 04/26/20

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT03075670 Org: User:
Start: 03/07/17 End: 12/08/17 Due: 12/08/18

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT02141074 Org: User:
Start: 07/02/14 End: 10/27/22 Due: 10/27/23

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01527552 Org: User:
Start: 11/05/02 End: 12/18/02 Due: 12/18/03

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

Phase: N/A Priority: Normal
NCT ID: NCT00294723 Org: User:
Start: 02/28/06 End: 11/30/08 Due: 11/30/09

A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01623375 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Efficacy on Height in SGA Children Treated With Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT00184756 Org: User:
Start: 11/30/02 End: 07/31/06 Due: 07/31/07

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

Phase: N/A Priority: Normal
NCT ID: NCT02963935 Org: User:
Start: 02/06/17 End: 06/19/18 Due: 06/19/19

A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05996874 Org: User:
Start: 08/12/23 End: 04/18/24 Due: 04/18/25

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05230589 Org: User:
Start: 01/11/22 End: 03/13/23 Due: 03/13/24

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

Phase: N/A Priority: Normal
NCT ID: NCT03847909 Org: User:
Start: 10/28/19 End: 06/29/21 Due: 06/29/22